MXPA05011428A - Metodo de tratamiento de fibrilacion atrial o trepidacion auricular. - Google Patents

Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.

Info

Publication number
MXPA05011428A
MXPA05011428A MXPA05011428A MXPA05011428A MXPA05011428A MX PA05011428 A MXPA05011428 A MX PA05011428A MX PA05011428 A MXPA05011428 A MX PA05011428A MX PA05011428 A MXPA05011428 A MX PA05011428A MX PA05011428 A MXPA05011428 A MX PA05011428A
Authority
MX
Mexico
Prior art keywords
atrial
flutter
treating
fibrillation
atrial fibrillation
Prior art date
Application number
MXPA05011428A
Other languages
English (en)
Inventor
Shawn Mcdonald
Original Assignee
Aderis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aderis Pharmaceuticals Inc filed Critical Aderis Pharmaceuticals Inc
Publication of MXPA05011428A publication Critical patent/MXPA05011428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Abstract

La presente invencion se relaciona con el uso de N6-ciclopentil-5??-(N-etil) carboxamidoadenosina (DTI-0009) o una sal o ester farmaceuticamente aceptable del mismo en el tratamiento de fibrilacion auricular o aleteo auricular en un humano. Especialmente por el metodo de esta invencion se trata un ataque agudo de fibrilacion auricular o aleteo auricular.
MXPA05011428A 2003-04-24 2004-04-26 Metodo de tratamiento de fibrilacion atrial o trepidacion auricular. MXPA05011428A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46495703P 2003-04-24 2003-04-24
US51400903P 2003-10-27 2003-10-27
PCT/US2004/012731 WO2004100964A1 (en) 2003-04-24 2004-04-26 Method of treating atrial fibrillation or atrial flutter

Publications (1)

Publication Number Publication Date
MXPA05011428A true MXPA05011428A (es) 2006-05-31

Family

ID=33457011

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011428A MXPA05011428A (es) 2003-04-24 2004-04-26 Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.

Country Status (6)

Country Link
US (1) US20050009776A1 (es)
EP (1) EP1633371A1 (es)
AU (1) AU2004238217A1 (es)
CA (1) CA2523746A1 (es)
MX (1) MXPA05011428A (es)
WO (1) WO2004100964A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005025545A2 (en) * 2003-09-17 2005-03-24 Aderis Pharmaceuticals, Inc. Pharmaceutical formulation for controlled release of selodenoson
WO2008066745A1 (en) 2006-11-22 2008-06-05 Reliant Pharmaceuticals, Inc. Prophlyaxis and treatment of atrial fibrillation with omega-3 fatty acids
EP3552602A1 (en) * 2009-03-18 2019-10-16 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
GB2552856A (en) 2016-02-01 2018-02-14 Incarda Therapeutics Inc Combining electronic monitoring with inhaled pharmacological therapy to manage atrial arrhythmias including atrial fibrillation
CN110869018A (zh) 2017-05-10 2020-03-06 英凯达治疗公司 通过肺部施用治疗心脏病况的单位剂量、气雾剂、试剂盒和方法
EP3768378A4 (en) 2018-03-22 2021-11-17 InCarda Therapeutics, Inc. INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128629C (es) * 1966-05-07
SE329623B (es) * 1967-06-08 1970-10-19 C F Boehringer Soehne Gmbh
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
DE2007273A1 (de) * 1970-02-18 1971-08-26 Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof N(6) Aralkyl adenosin Derivate und Verfahren zur Herstellung derselben
US4224438A (en) * 1970-07-14 1980-09-23 Boehringer Mannheim Gmbh Adenosine-5'-carboxylic acid amides
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
US4029884A (en) * 1971-03-18 1977-06-14 Abbott Laboratories Adenosine-5'-carboxylic acid amides
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
US4090021A (en) * 1971-10-08 1978-05-16 Schering Aktiengesellschaft Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
US3966916A (en) * 1972-09-09 1976-06-29 Boehringer Mannheim G.M.B.H. N(6)-disubstituted adenoisine compounds and therapeutic compositions
US3931401A (en) * 1972-10-21 1976-01-06 Abbott Laboratories 1,N6 -etheno-5'-adenosine carboxamides for increasing coronary sinus partial pressure of oxygen
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US4673563A (en) * 1980-10-14 1987-06-16 The University Of Virginia Alumni Patents Foundation Adenosine in the treatment of supraventricular tachycardia
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
US4738954A (en) * 1985-11-06 1988-04-19 Warner-Lambert Company Novel N6 -substituted-5'-oxidized adenosine analogs
US4868160A (en) * 1985-11-06 1989-09-19 Warner-Lambert Company Method of treating psychosis using N6 -substituted -5'-oxidized adenosine analogs
US5219840A (en) * 1987-04-06 1993-06-15 Sandoz Ltd. Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DK0550631T3 (da) * 1990-09-25 1997-01-20 Rhone Poulenc Rorer Int Forbindelser med blodtrykssænkende virkning og virkning mod iskæmi
FR2687678B1 (fr) * 1992-01-31 1995-03-31 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5424297A (en) * 1992-04-27 1995-06-13 University Of Virginia Alumni Patents Foundation Adenosine dextran conjugates
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
WO1997024327A1 (en) * 1996-01-02 1997-07-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
EP0991414A4 (en) * 1997-05-09 2002-10-02 Univ Pennsylvania METHODS FOR REDUCING CARDIAC ISCHEMIC LESION BY ADMINISTRATION OF ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS AND RELATED COMPOSITIONS
US6048865A (en) * 1997-07-29 2000-04-11 Medco Research, Inc. N6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator
US6329349B1 (en) * 1997-10-23 2001-12-11 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents
US6784165B1 (en) * 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
IL149470A0 (en) * 1999-11-23 2002-11-10 Aderis Pharmaceuticals Inc Pharmaceutical compositions containing carboxamidoadenosine derivatives
US6576620B2 (en) * 1999-12-03 2003-06-10 Cv Therapeutics, Inc. Method of identifying partial adenosine A1 receptor agonists

Also Published As

Publication number Publication date
EP1633371A1 (en) 2006-03-15
WO2004100964A1 (en) 2004-11-25
US20050009776A1 (en) 2005-01-13
CA2523746A1 (en) 2004-11-25
AU2004238217A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
AU2003297356A1 (en) Prevention and treatment of cardiac arrhythmias
IL157016A0 (en) Atrial ablation catheter and method for treating atrial fibrillation
AU2003224788A1 (en) Method for treatment of tissue
EP1666090A4 (en) HEART TREATMENT DEVICE AND METHOD FOR HEART TREATMENT
WO2002003872A3 (en) Application of photochemotherapy for the treatment of cardiac arrhythmias
WO2000061167A3 (en) TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS
AU2003291165A1 (en) Treating arrhythmias by altering properties of tissue
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
GB0223038D0 (en) Therapeutic compounds
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
ATE421329T1 (de) Verwendung von aplidine zur behandlung von kardiovaskulären erkrankungen
HK1099918A1 (en) Composition and use for prevention or treatment of stomatitis
MXPA05011428A (es) Metodo de tratamiento de fibrilacion atrial o trepidacion auricular.
DE60001555T2 (de) Wässrige lösung zum konservieren von gewebe und organen
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
PL378325A1 (pl) Kompozycja do stosowania miejscowego i sposoby leczenia skóry starzejącej się lub uszkodzonej przez środowisko
WO2004004653A3 (en) Methods for treating psychosis associated with interferon-alpha therapy
WO2004033660A3 (en) Gene expression profiling from ffpe samples
DE60312723D1 (de) Herzstimulation zur erweiterung der refraktärzeit des vorhofs
DE69920015D1 (de) Verfahren zur induktion der herstellung von wachstumsfaktoren
WO2003092669A3 (en) Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
NO20030081L (no) Anvendelse av stammer fra parapoxvirus mot organfibroser